Early relapse of Burkitt lymphoma heralded by a bone marrow necrosis and numb chin syndrome successfully treated with allogeneic stem cell transplantation

Jan Cerny; Katherine Devitt; Hongbo Yu; Muthalagu Ramanathan; Bruce Woda; Rajneesh Nath

doi:10.1016/j.lrr.2014.06.002

Leukemia Research Reports (Jan 2014)

Early relapse of Burkitt lymphoma heralded by a bone marrow necrosis and numb chin syndrome successfully treated with allogeneic stem cell transplantation

Jan Cerny,
Katherine Devitt,
Hongbo Yu,
Muthalagu Ramanathan,
Bruce Woda,
Rajneesh Nath

Affiliations

Jan Cerny: Division of Hematology Oncology, Department of Medicine, UMass Memorial Medical Center, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA
Katherine Devitt: Department of Pathology, UMass Memorial Medical Center, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA
Hongbo Yu: Department of Pathology, UMass Memorial Medical Center, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA
Muthalagu Ramanathan: Division of Hematology Oncology, Department of Medicine, UMass Memorial Medical Center, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA
Bruce Woda: Department of Pathology, UMass Memorial Medical Center, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA
Rajneesh Nath: Division of Hematology Oncology, Department of Medicine, UMass Memorial Medical Center, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA

DOI: https://doi.org/10.1016/j.lrr.2014.06.002
Journal volume & issue: Vol. 3, no. 2
pp. 51 – 53

Abstract

Read online

The optimal salvage therapy for patients with relapsed Burkitt lymphoma is unknown. Bone marrow necrosis is an underreported (2 years after the transplant. To our knowledge, this is the longest reported survival of the two syndromes in the setting of BL relapse.

Published in Leukemia Research Reports

ISSN: 2213-0489 (Online)
Publisher: Elsevier
Country of publisher: Netherlands
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: http://www.journals.elsevier.com/leukemia-research-reports/

About the journal

Abstract

Keywords